These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 29785508)
1. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy. Hoy SM CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508 [TBL] [Abstract][Full Text] [Related]
2. Lacosamide: A Review in Focal Seizures in Patients with Epilepsy. Scott LJ Drugs; 2015 Dec; 75(18):2143-54. PubMed ID: 26607484 [TBL] [Abstract][Full Text] [Related]
3. Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures. Hoy SM CNS Drugs; 2013 Dec; 27(12):1125-42. PubMed ID: 24203890 [TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study. Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275 [TBL] [Abstract][Full Text] [Related]
5. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study. Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy. Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195 [TBL] [Abstract][Full Text] [Related]
7. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain. Harris JA; Murphy JA Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834 [TBL] [Abstract][Full Text] [Related]
8. Lacosamide as a first-line treatment option in focal epilepsy: a cost-utility analysis for the Greek healthcare system. Geitona M; Stamuli E; Giannakodimos S; Kimiskidis VK; Kountouris V; Charokopou M; Christou P J Med Econ; 2019 Apr; 22(4):359-364. PubMed ID: 30652931 [TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real-world study. Yang L; Liu Y; Deng Y; Peng X; Hu Q; Jiang L; Hu Y CNS Neurosci Ther; 2024 Aug; 30(8):e14917. PubMed ID: 39123302 [TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years. Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P; Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210 [TBL] [Abstract][Full Text] [Related]
13. Review of therapeutic options for adjuvant treatment of focal seizures in epilepsy: focus on lacosamide. Becerra JL; Ojeda J; Corredera E; Ruiz Giménez J CNS Drugs; 2011 Dec; 25 Suppl 1():3-16. PubMed ID: 22141347 [TBL] [Abstract][Full Text] [Related]
14. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting. Sanmartí-Vilaplana F; Díaz-Gómez A Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216 [TBL] [Abstract][Full Text] [Related]
15. Eslicarbazepine Acetate: A Review in Focal-Onset Seizures. Heo YA CNS Drugs; 2020 Sep; 34(9):989-1000. PubMed ID: 32737793 [TBL] [Abstract][Full Text] [Related]
16. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting. Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial. Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118 [TBL] [Abstract][Full Text] [Related]
18. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial. Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S; Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101 [TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation. Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854 [TBL] [Abstract][Full Text] [Related]
20. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures. Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]